MeiraGTx Holdings plc stock is down -1.87% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 December’s closed higher than November.
MeiraGTx Holdings plc focuses on developing treatments for patients with serious diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop a gene therapy treatment using the company's proprietary riboswitch technology.